Literature DB >> 1327327

Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

T Mengden1, P Hubmann, J Müller, P Greminger, W Vetter.   

Abstract

We evaluated the usefulness of the basal urinary 24-h excretion rates of free cortisol versus 17-hydroxycorticosteroids in the diagnosis of Cushing's syndrome. On an outpatient basis, both urinary free cortisol and 17-hydroxycorticosteroids levels were determined in 48 patients with Cushing's syndrome, as well as in 95 obese and 94 healthy control persons of normal weight. Determination of the urinary free cortisol content allowed a clear-cut distinction between the patients with hypercortisolism and the controls, resulting in a sensitivity of 100% and specificity of 98% for the diagnosis of Cushing's syndrome. The diagnostic accuracy of urinary free cortisol was distinctly superior to that of 17-hydroxycorticosteroids, which showed a wide overlap of values between the groups, with a sensitivity of 73% and a specificity of 94%. In conclusion, the measurement of basal urinary free cortisol provided an excellent diagnostic sensitivity and specificity in the assessment of adrenocortical function. This simple and accurate test thus seems to be particularly useful in the outpatient evaluation of patients with suspected Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327327     DOI: 10.1007/bf00184788

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  16 in total

1.  STUDY OF ADRENOCORTICAL FUNCTION IN OBESITY.

Authors:  C J MIGEON; O C GREEN; J P ECKERT
Journal:  Metabolism       Date:  1963-08       Impact factor: 8.694

2.  Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

3.  Cushing's syndrome: a prospective study of diagnostic methods.

Authors:  R L Eddy; A L Jones; P F Gilliland; J D Ibarra; J Q Thompson; J F MacMurry
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

4.  The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives.

Authors:  D H Streeten; C T Stevenson; T G Dalakos; J J Nicholas; L G Dennick; H Fellerman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

5.  Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis.

Authors:  E J Ross; D C Linch
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

6.  Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome.

Authors:  G Vidal Trecan; M H Laudat; P Thomopoulos; J P Luton; H Bricaire
Journal:  Acta Endocrinol (Copenh)       Date:  1983-05

7.  Lack of specificity of cortisol determinations in human urine.

Authors:  B E Murphy; L M Okouneff; G P Klein; S C Ngo
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

8.  Short-term fluctuations in plasma cortisol in Cushing's syndrome.

Authors:  H Vetter; R Strass; J M Bayer; R Beckerhoff; H Armbruster; W Vetter
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

9.  [Special diagnosis in Cushing's syndrome].

Authors:  W Tenschert; H Vetter; R Siebenschein; B Holland-Cunz; W Siegenthaler; W Vetter
Journal:  Schweiz Med Wochenschr       Date:  1981-01-17
View more
  7 in total

Review 1.  Cushing's syndrome.

Authors:  V Bhatia
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Raised cortisol excretion rate in urine and contamination by topical steroids.

Authors:  C J Kelly; A Ogilvie; J R Evans; D Shapiro; A M Wallace; D L Davies
Journal:  BMJ       Date:  2001-03-10

3.  Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

Authors:  R Görges; G Knappe; H Gerl; M Ventz; F Stahl
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

4.  The effects of therapy with rifampicin and isoniazid on basic investigations for Cushing's syndrome.

Authors:  T H Zawawi; M S al-Hadramy; S M Abdelwahab
Journal:  Ir J Med Sci       Date:  1996 Oct-Dec       Impact factor: 1.568

5.  High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.

Authors:  T C Friedman; D E Ghods; H K Shahinian; L Zachery; N Shayesteh; S Seasholtz; E Zuckerbraun; M L Lee; I E McCutcheon
Journal:  Horm Metab Res       Date:  2010-08-27       Impact factor: 2.936

6.  Hair analysis provides a historical record of cortisol levels in Cushing's syndrome.

Authors:  S Thomson; G Koren; L-A Fraser; M Rieder; T C Friedman; S H M Van Uum
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-07-16       Impact factor: 2.949

7.  The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.

Authors:  L Vilar; M C Freitas; L A Naves; V Canadas; J L Albuquerque; C A Botelho; C S Egito; M J Arruda; L M Silva; C M Arahata; R Agra; L H C Lima; M Azevedo; L A Casulari
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.